Yield10 Bioscience, Inc.Yield10 Bioscience, Inc.Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc.

No trades
See on Supercharts
Market capitalization
‪4.39 M‬USD
−2.0850USD
‪−14.46 M‬USD
‪60.00 K‬USD
‪12.41 M‬
Beta (1Y)
0.90

About Yield10 Bioscience, Inc.

CEO
Oliver P. Peoples
Headquarters
Woburn
Employees (FY)
29
Founded
1992
ISIN
US98585K8624
FIGI
BBG000J1XKK3
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of YTEN is 0.28 USD — it has decreased by 2.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Yield10 Bioscience, Inc. stocks are traded under the ticker YTEN.
Yield10 Bioscience, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Yield10 Bioscience, Inc. has a max estimate of 0.50 USD and a min estimate of 0.50 USD.
YTEN earnings for the last quarter are −0.41 USD whereas the estimation was −0.39 USD which accounts for −4.24% surprise. Estimated earnings for the next quarter are −0.31 USD. See more details about Yield10 Bioscience, Inc. earnings.
Yield10 Bioscience, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪33.33 K‬ USD. In the next quarter revenue is expected to reach ‪75.00 K‬ USD.
Yes, you can track Yield10 Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, YTEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Yield10 Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
YTEN reached its all-time high on Oct 30, 2007 with the price of 71409.69 USD, and its all-time low was 0.18 USD and was reached on Dec 11, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 29.00 employees. See our rating of the largest employees — is Yield10 Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Yield10 Bioscience, Inc. EBITDA is ‪−14.02 M‬ USD, and current EBITDA margin is ‪−23.55 K‬%. See more stats in Yield10 Bioscience, Inc. financial statements.